Divi's Laboratories Share Price
Large Cap | Pharmaceuticals and health care | NSE: DIVISLAB | BSE: 532488
₹5,622.50 
46.60 (0.84 %)
Last Updated: 01 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 5,599.95
High (₹) 5,653.95
Low (₹) 5,508.50
Prev. Close (₹) 5,575.90
Volume 4,878
VWAP (₹) 5,605.11
ROCE (%) 15.26
Industry P/E 46.23
TTM P/E 81.30
P/B Ratio 10.97
Market Cap (₹) Cr.1,49,154.85
Dividend Yield (%)0.53
EPS (₹) 60.27
ROE11.77%
Sales Growth (%) 1.00
Profit Growth (%)-12.25
Day Range
5,653.955,653.95
52 Week Range
3,350.056,448.75
Historical Returns
Returns (6M)
16.5 %
Returns (1Y)
52.04 %
Returns (3Y)
31.95 %
Returns (5Y)
186.6 %
Returns (6M)
16.5 %
Returns (1Y)
52.04 %
Returns (3Y)
31.95 %
Returns (5Y)
186.6 %
SWOT Analysis
- Company with no debt
- Book value per share improving over the last 2 years
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
Technicals
Technical Rating
BEARISHRSI 45.31
MFI 21.75
ATR 193.88
Commodity Channel Index -105.89
ROC125 13.27
ROC21 -8.59
Williams %R -68.91
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 5,691.81 | 5,807.73 | 5,880.91 | 5,618.63 | 5,502.71 | 5,429.53 | 5,313.61 |
| Week Ago | 5,872.36 | 5,978.53 | 6,062.11 | 5,788.78 | 5,682.61 | 5,599.03 | 5,492.86 |
| Month Ago | 6,163.54 | 6,227.32 | 6,319.74 | 6,071.12 | 6,007.34 | 5,914.92 | 5,851.14 |
EMA & SMA
5622.50
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
16
5 Day 5578.94
9 Day 5711.38
10 Day 5766.91
12 Day 5776.20
14 Day 5805.85
20 Day 5852.43
26 Day 5848.81
50 Day 5920.40
100 Day 5792.43
200 Day 5111.72
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| RONDURE NEW WORLD FUND | block | Sell | 20 Oct, 2023 | ₹3,637.70 | 43,478 | BSE |
| NORTHERN LIGHTS FUND TRUST III RONDURE NEW WORLD FUND | block | Buy | 20 Oct, 2023 | ₹3,637.70 | 43,478 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 25 Oct, 2022 | ₹3,612.00 | 1,12,509 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 25 Oct, 2022 | ₹3,612.00 | 1,12,509 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 17 Oct, 2022 | ₹3,572.80 | 1,76,805 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 17 Oct, 2022 | ₹3,572.80 | 1,76,805 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 11 Oct, 2022 | ₹3,686.60 | 1,72,889 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 11 Oct, 2022 | ₹3,686.60 | 1,72,889 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 19 Sept, 2022 | ₹3,573.70 | 1,17,596 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 19 Sept, 2022 | ₹3,573.70 | 1,17,596 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 28 Dec, 2024 | Y. Sreedevi | Acquisition | ₹5,874.00 | 1,400 | BSE |
| 28 Dec, 2024 | Y K Chowdary | Disposal | ₹5,874.00 | 1,400 | BSE |
| 20 Dec, 2024 | P. Rama Sekhar | Acquisition | ₹6,005.74 | 500 | BSE |
| 09 Dec, 2024 | S Rajani | Disposal | ₹6,210.00 | 100 | BSE |
| 27 Nov, 2024 | Divi Madhusudana Rao | Disposal | ₹6,071.20 | 5,000 | BSE |
| 27 Nov, 2024 | M.Ramesh Babu | Disposal | ₹6,022.00 | 500 | BSE |
| 22 Nov, 2024 | Ch. Venu | Disposal | ₹5,992.50 | 200 | BSE |
| 15 Nov, 2024 | L. Lakshmi | Acquisition | ₹5,917.733333333333333333333333 | 1,500 | BSE |
| 27 Sept, 2024 | Y. KAMALAKAR | Disposal | ₹5,356.666666666666666666666667 | 750 | BSE |
| 14 Sept, 2024 | K. Sridevi | Disposal | ₹5,425.00 | 100 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 27 May, 2024 | Rs.30.0000 per share(1500%)Final Dividend | 02 Aug, 2024 | 02 Aug, 2024 |
| 22 May, 2023 | Rs.30.0000 per share(1500%)Final Dividend | 11 Aug, 2023 | 11 Aug, 2023 |
| 23 May, 2022 | Rs.30.0000 per share(1500%)Dividend | 11 Aug, 2022 | 12 Aug, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 28 Jan, 2025 | BSE India | Schedule of earnings conference call for Q3FY25 |
| 28 Jan, 2025 | NSE India | Divi''s Laboratories Limited has informed the Exchange about Schedule of meet |
| 23 Jan, 2025 | NSE India | Divi''s Laboratories Limited has informed the Exchange about Board Meeting to be held on 03-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . |
| 13 Jan, 2025 | NSE India | Divi''s Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
| 02 Jan, 2025 | BSE India | As per enclosed letter. |
| 02 Jan, 2025 | NSE India | Divi''s Laboratories Limited has informed the Exchange about commencement of commercial operations at Unit III greenfield project at Kakinada, Andhra Pradesh in phased manner. |
| 31 Dec, 2024 | NSE India | DIVI''S LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window |
| 31 Dec, 2024 | NSE India | Divi''s Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 05 Dec, 2024 | BSE India | As per enclosed letter. |
| 05 Dec, 2024 | NSE India | The Exchange has sought clarification from Divi''s Laboratories Limited with respect to recent news item captioned Divi''s Labs shares fall nearly 3% as US court says Novartis cannot block generic of best-selling heart drug. The response from the Company is attached. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 24 Jan, 2025 | 03 Feb, 2025 |
| Quarterly Results | -- | 30 Oct, 2024 | 09 Nov, 2024 |
| Quarterly Results | -- | 26 Jul, 2024 | 03 Aug, 2024 |
| Audited Results & Dividend | -- | 16 May, 2024 | 25 May, 2024 |
| Quarterly Results | -- | 31 Jan, 2024 | 10 Feb, 2024 |
| Quarterly Results | -- | 27 Oct, 2023 | 06 Nov, 2023 |
| Quarterly Results | -- | 09 Aug, 2023 | 14 Aug, 2023 |
| Audited Results & Final Dividend | -- | 15 May, 2023 | 20 May, 2023 |
| Quarterly Results | -- | 24 Jan, 2023 | 03 Feb, 2023 |
| Quarterly Results | -- | 31 Oct, 2022 | 07 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Divi's Laboratories
Divi's Laboratories is a Public Limited Listed company incorporated on 12/10/1990 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1990PLC011854 and registration number is 011854. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company’s Total Operating Revenue is Rs. 7665.00 Cr. and Equity Capital is Rs. 53.00 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1990
Managing Director
Dr. Murali K Divi
NSE Symbol
DIVISLAB
Divi's Laboratories Management
| Name | Designation |
|---|---|
| Dr. Ramesh B V Nimmagadda | Non Exe.Chairman&Ind.Director |
| Dr. Murali K Divi | Managing Director |
| Dr. Kiran S Divi | WholeTime Director & CEO |
| Ms. Nilima Prasad Divi | Whole Time Director |
| Dr. S Devendra Rao | Whole Time Director |
| Mr. N V Ramana | Executive Director |
| Mr. K V Chowdary | Independent Director |
| Dr. S Ganapaty | Independent Director |
| Prof. Sunaina Singh | Independent Director |
| Dr. Rajendra Kumar Premchand | Independent Director |
| Mr. K V K Seshavataram | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,742.20  ₹1,743.95(-0.10%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,618.55  ₹5,577.70(0.73%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,439.50 ₹1,479.40(-2.70%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,481.60 ₹2,435.40(1.90%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,204.95 ₹1,217.35(-1.02%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Divi's Laboratories
What is the share price of Divi's Laboratories?
The share price of Divi's Laboratories on 01 Feb, 2025 is ₹ 5,622.50.
What is 52W high and 52W low share price of Divi's Laboratories?
The highest and lowest 52W share prices of Divi's Laboratories are ₹ 6448.750 and ₹ 3350.050
What is the market cap of Divi's Laboratories?
The market capitalization of Divi's Laboratories as of 01 Feb, 2025 is ₹ 1,49,154.85 Crores
What is the P/E ratio of Divi's Laboratories?
The current P/E ratio of Divi's Laboratories as of 01 Feb, 2025 is 46.23
What is the PB ratio of Divi's Laboratories?
The PB ratio of Divi's Laboratories as of 01 Feb, 2025 is 10.97
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)